Cancer of the Prostate – Cancer Stat Facts
Prostate Cancer statistics
Related Articles
Anemia During Ruxolitinib Treatment Is Associated With Worse Outcomes for Patients With MF | Blood Cancers Today
In the real-world setting, patients with MF and anemia who were treated with ruxolitinib had poorer survival outcomes than patients without anemia.
Oncology Center of Excellence Guidance Documents
Recently added guidance documents regarding oncology and malignant hematology
Spotlight on Seasonal Depression: Why Indoor Tanning Isn’t an Effective Treatment
Seasonal Affective Disorder (SAD) affects millions of Americans, but hopping into a tanning bed won’t help. Visible light therapy is safer.
Social determinants of health and US cancer screening interventions: A systematic review
There remains a need to synthesize linkages between social determinants of health (SDOH) and cancer screening to reduce persistent inequities contributing to the US cancer…
Home | Multiple Myeloma Hub
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
OCE ENGAGE: A Project Community Newsletter
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers
Medical Student Q&A – Medical Students – American Society for Radiation Oncology (ASTRO) – American Society for Radiation Oncology (ASTRO)
Join us for our bi-monthly Medical Student Q&A where you will have the opportunity to meet faculty and resident radiation oncologists.
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
We Are Looking For A Clinical Research Physician
The Clinical Research Physician provides medical expertise and support for the development, implementation, conduct and reporting of EORTC clinical trials.
FDA Approves Ensartinib for Locally Advanced or Metastatic ALK+ NSCLC
The FDA has approved ensartinib for patients with ALK+ locally advanced or metastatic NSCLC who have not previously received an ALK inhibitor.
